He also serves as Associate Research Professor at the Barcelona Institute for Global Health (ISGlobal) in Spain. His decade-long career as a health systems, HIV and viral hepatitis expert at WHO’s Regional Office for Europe was followed by three years at the Global Fund to Fight AIDS, Tuberculosis and Malaria. He is the past Vice-Chair of the EASL International Liver Foundation, Board Chair of AFEW International, and he was the first director of Health Systems Global. He currently serves as a steering committee member of the Global NASH Council and a member of the EASL Public Health and Policy Committee, where he leads the global Healthy Livers, Healthy Lives coalition. He is the author of more than 400 publications, including leading the landmark Global COVID-19 Consensus Statement (Nature 2022) and multiple global studies on COVID-19 vaccines hesitancy including in Nature Medicine (2020 and 2023). He is a co-author of The Lancet COVID-19 Commission, the Lancet GastroHep Commission on viral hepatitis, the EASL-Lancet European Liver Commission and led The Lancet HIV series on HIV Beyond Viral Suppression. Prof Lazarus is co-chair of the Innovations in SLD Care Thinktank. He has been advising governments, NGOs and WHO, as well as frequently appearing in the media to address pressing issues about the pandemic. He is on the editorial board of HIV Medicine, the International Journal of Drug Policy and the Journal of Hepatology. In 2023, he received the American Liver Foundation Distinguished Scientific Achievement Award.
Steatotic Liver Disease (MASLD/MASH), Health systems; Public health and policy Viral hepatitis